Clinical Trials Directory

Trials / Completed

CompletedNCT02554357

Quality of Analgesia After Interscalene Block After Arthroscopic Shoulder Surgery

Quality of Analgesia After Interscalene Block With Bupivacaine and Exparel® vs. Bupivacaine Alone After Arthroscopic Shoulder Surgery

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
North American Institute for Continuing Medical Education (NAICE) · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

Shoulder arthroscopic causes post operative pain that outlasts analgesia provided by single injection nerve blocks.

Detailed description

The interscalene brachial plexus block (ISBPB) is a common analgesic technique for procedures of the shoulder and upper arm. Moreover, the incidence of rebound pain is well documented and is often of considerable discomfort to patients, who may quickly go from little or no pain to moderate-severe pain. Continuous nerve block techniques with home ambulatory catheters are currently utilized to manage postoperative pain.This study is designed to compare the level and duration of pain control of Exparel® injected after bupivacaine via stop-cock connected syringes and bupivacaine alone for ISBPB.

Conditions

Interventions

TypeNameDescription
DRUGExparel block in arthroscopic shoulder surgeryThe interscalene block will be performed with ultrasound guidance and nerve stimulation.
DRUGBupivacaine block in shoulder surgeryThe interscalene block will be performed with ultrasound guidance and nerve stimulation.

Timeline

Start date
2015-07-01
Primary completion
2016-01-01
Completion
2016-03-01
First posted
2015-09-18
Last updated
2016-09-08

Locations

2 sites across 1 country: Belgium

Source: ClinicalTrials.gov record NCT02554357. Inclusion in this directory is not an endorsement.